Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Canaccord Genuity Growth Conference Transcript

Aug 08, 2019 / 05:30PM GMT
Release Date Price: $110.3 (+0.55%)
Mark Anthony Massaro
Canaccord Genuity Corp., Research Division - Senior Analyst

We're pleased to have Guardant Health with us today. Guardant is about a $10 billion, $11 billion market cap leader in liquid biopsies. The company IPO-ed in October 2018 at around $19 a share. The stock today is over $100. It was the largest IPO in the history of my sector.

Guardant works with over 50 of the most important biopharma companies in the world and they've pioneered liquid biopsy comprehensive profiling with their market-leading Guardant360 panel. Helmy is the company's Co-Founder, President and CEO. And to my left, we have Derek Bertocci, the company's Chief Financial Officer. Guys, thank you very much.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

Thank you for having us.

Questions & Answers

Mark Anthony Massaro
Canaccord Genuity Corp., Research Division - Senior Analyst

So I guess the first question for you, Helmy, since you cofounded the company, you and AmirAli developed a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot